Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJun 14, 2017Estradiol 12.5 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0894-2017Class IITerminatedJun 14, 2017Estradiol 15 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0893-2017Class IITerminatedJun 14, 2017Estradiol 18 mg pelletCGMP deviations- Lack of Quality AssuranceQualgen · D-0892-2017Class IITerminatedJun 14, 2017Estradiol 20 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0891-2017Class IITerminatedJun 14, 2017Estradiol 22 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0890-2017Class IITerminatedJun 14, 2017Estradiol 25 mg pellet 99.5% Estradiol USPCGMP deviations- Lack of Quality AssuranceQualgen · D-0889-2017Class IITerminatedJun 14, 2017methylcobalamin 1mg/1mLLack of Assurance of SterilityMedPark Pharmacy, LLC · D-0888-2017Class IITerminatedJun 14, 2017Option 2Defective Container: Carton is missing the tablet blister strip and tablet.L. Perrigo Company · D-0887-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0886-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0885-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0884-2017Class IITerminatedJun 14, 2017ZenataneFailed Dissolution Specifications: out of specification results observed for low dissolution.Dr. Reddy's Laboratories, Inc. · D-0883-2017Class IITerminatedJun 14, 2017LevonorgestrelCGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for...Spectrum Laboratory Products, Inc. · D-0882-2017Class IITerminatedJun 14, 2017EstradiolCGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for...Spectrum Laboratory Products, Inc. · D-0881-2017Class IITerminatedJun 7, 2017Saphris 10 mgLabeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tabletsForest Laboratories, LLC · D-0880-2017Class IITerminatedJun 7, 2017PHENYLephrine HCL in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0879-2017Class IITerminatedJun 7, 2017MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0878-2017Class IITerminatedJun 7, 2017ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0877-2017Class IITerminatedJun 7, 2017ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0876-2017Class IITerminatedJun 7, 2017HYDROmorphone HCL in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0875-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0874-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0873-2017Class IITerminatedJun 7, 2017fentaNYLLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0872-2017Class IITerminatedJun 7, 2017morphine sulfate in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0871-2017Class IITerminatedJun 7, 2017morphine sulfate in 0.9% Sodium Chloride injectableLack of assurance of sterility: Product bags leaking at seam.SCA Pharmaceuticals · D-0870-2017Class IIITerminatedJun 7, 2017Nystatin Oral SuspensionFailed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.VistaPharm, Inc. · D-0869-2017Class IIITerminatedJun 7, 2017Amoxicillin and Clavulanate Potassium TabletsSubpotent Drug; Clavulanic AcidSandoz Inc · D-0868-2017Class ITerminatedMay 31, 2017LaBri's Body Health AtomicMarketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.Envy Me · D-0867-2017Class IITerminatedMay 31, 2017Shield and Protect Moisture Barrier CreamGMP Deviations; product may not meet cGMP requirementsGentell, Inc · D-0866-2017Class IITerminatedMay 31, 2017Refresh TearsLabeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.Cell Distributors · D-0865-2017Class ITerminatedMay 31, 2017Hyland's Baby Nighttime Teething Tablets [Belladonna 12X HPUSSuperpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.Standard Homeopathic Company · D-0864-2017Class ITerminatedMay 31, 2017Hyland's Baby Teething Tablets [Calcarea Phosporica 6X HPUSSuperpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.Standard Homeopathic Company · D-0863-2017Class IOngoingMay 31, 2017Infant 25% DEXTROSE InjectionPresence of Particulate Matter: human hair found within an internal sample syringe.Hospira Inc. · D-0862-2017Class IIITerminatedMay 31, 2017Norethindrone Acetate and Ethinyl Estradiol TabletsChemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner...Mylan Pharmaceuticals Inc. · D-0861-2017Class IIITerminatedMay 31, 2017Tarina Fe 1/20Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner...Mylan Pharmaceuticals Inc. · D-0860-2017Class IIITerminatedMay 31, 2017HYDROCORTISONE LOTIONSuperpotent Drug: above specification for the assay.Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals · D-0859-2017Class IIITerminatedMay 31, 2017Benzonatate capsulesFailed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.Strides Pharma INC · D-0858-2017Class IIITerminatedMay 31, 2017Children's Cetirizine Hydrochloride Chewable TabletsFailed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.Sun Pharmaceutical Industries, Inc. · D-0857-2017Class IITerminatedMay 31, 2017DORAMA-NEOLack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.Sato Pharmaceutical Inc. · D-0856-2017Class IITerminatedMay 31, 2017SATO CLEARLack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.Sato Pharmaceutical Inc. · D-0855-2017

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.